Introduction
Dendritic cells (DCs) are antigen-presenting cells (APCs) that exist widely in the body and survey pathogen invasions [1] . Upon recognition of pathogens, DCs present peptide antigens via major histocompatibility complex (MHC) molecules to the T cells. DCs also present lipid antigen via nonclassical MHC CD1 to natural killer T cells (NKT cells) [2] , inducing robust cytokine production.
DCs are primarily divided into two populations: conventional DCs (cDCs) and plasmacytoid DCs (pDCs) [3] . cDCs are further subdivided into two groups, CD8
+ and CD8 -DCs, by the expression of CD8α [4] . NKT cells are divided into two subsets by the pattern of T cell antigen receptor (TCR) expression. Type I NKT cells express invariant TCR, so they are designated as invariant NKT (iNKT) cells [5] . iNKT cells recognize marine sponge α-galactosylceramide (αGC) on the CD1d molecule of cDCs, inducing antitumor activity via the robust production of IFN-γ. During interaction with cDCs, iNKT cells express CD40 ligand (CD40L), which stimulates cDCs via their CD40, subsequently inducing IL-12 production from CD8 + DCs. In turn, IL-12 stimulates iNKT cells, resulting in the strong production of IFN-γ [6, 7] Furthermore, using Langerin-eGFP-diphtheria toxin receptor (DTR) mice, depletion of Langerin + cDCs decreased IL-12 and IFN-γ production after stimulation with injection of αGC [8] , suggesting that Langerin + CD8 + DCs are involved in IFN-γ production of iNKT cells in vivo. However, it is unclear why CD8 + DCs induce higher IFN-γ production of iNKT cells than CD8 -DCs. Here, we compared αGC uptake and degradation between CD8 -and CD8 + DC subsets using Cy5-conjugated αGC (Cy5-αGC). We also performed histological analyses to observe the uptake of Cy5-αGC in the spleen. Our results suggest that both cellular properties and localization of CD8 + DCs enable efficient stimulation of iNKT cells in response to αGC.
Materials and Methods

Mice
C57BL/6 (B6) and BALB/c mice were purchased from Japan SLC (Hamamatsu, Shizuoka, Japan), Jα18 knock out (KO) mice (B6 background) were provided from Dr.
Taniguchi (RIKEN RCAI, Yokohama, Japan), and Langerin-diphtheria toxin receptor (DTR) mice (B6 background) were provided by Dr. Kabashima (Kyoto University, Kyoto, Japan).
All mice were housed under specific pathogen-free conditions and used at 7-12 wk of age. All experiments were conducted according to our institutional guidelines.
Reagents and antibodies
αGC (Funakoshi Co., Ltd., Tokyo, Japan) was dissolved at 200 µg/ml in 0.5%
Tween-20 in PBS. Cy5-αGC was provided from Dr. Watarai (The University of Tokyo, Tokyo, Japan). Diphtheria toxin (DT) and 30% bovine serum albumin (BSA) solution were purchased from Sigma-Aldrich (St Louis, MO). 7-Aminoactinomycin D (7-AAD) was purchased from Kyoto, Japan), respectively. Anti-CXCL16 mAb was biotinylated in our laboratory.
Anti-SER4 mAb was purified from culture supernatant of hybridoma and biotinylated in our laboratory. Streptavidin-PE was purchased from BD Biosciences. Cy3-conjugated anti-rat IgG was purchased from Jackson ImmunoResearch Europe Ltd. (Cambridgeshire, UK).
Hybridomas producing anti-CD16/32 mAb (2.4G2) were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA), and culture supernatants were produced in our laboratory.
MACS microbeads conjugated with anti-mouse CD11c and FITC were purchased from Miltenyi Biotec GmbH (Bergisch Gladbach, Germany).
Cell preparation
cDCs were prepared as follows: spleens were treated with 400 U/ml collagenase D (Roche, Mannheim, Germany) for 45 min at 37°C, and suspended. Subsequently, low density cells were obtained by centrifugation at 800 × g for 30 min using 30% BSA. CD11c + cells
were purified from the cells using anti-CD11c microbeads following the manufacturer's protocol. To check depletion of CD8 + DCs by DT treatment, whole splenocytes after the collagenase digestion were subjected to flow cytometry. For measurement of CXCL16 on the cell surface, the spleen was dispersed in 5 mM EDTA in PBS and whole splenocytes were analyzed using flow cytometry.
Flow cytometry of cell populations and Cy5-αGC uptake
Fc receptors on cells were blocked with anti-CD16/32 mAb in staining buffer for 30 min on ice, and stained for 30 min on ice with mAbs. Data were collected on FACSCalibur and were analyzed with FlowJo (TreeStar, Ashland, OR). Net MFI was obtained by subtraction of the isotype mAb MFI from that of specific mAb.
For the in vivo assay of Cy5-αGC uptake, Jα18 KO mice were injected i.v. with 5 µg For the in vitro assay of Cy5-αGC uptake, cDCs stained with anti-CD11c-FITC and anti-CD8-PE were cultured in the presence of graded doses of Cy5-αGC for 1 h, or of 100 ng/mL αGC for various time points. After incubation, Cy5-fluorescence intensity was measured gating on CD11c + CD8 + and CD11c + CD8 -by flow cytometry. Autofluorescence intensity and background binding of Cy5-αGC by cDCs were calculated by subtraction of fluorescence intensity (MFI) of cDCs cultured with Cy5-αGC at 4ºC from that of cDCs cultured at 37ºC. In pulse and chase experiments, net MFI was calculated by subtraction of autofluorescence intensity of cDCs from MFI of cDCs cultured with Cy5-αGC at 37ºC.
The % reduction was calculated using the following formula: [MFI of Cy5-αGC at the time point / that at the initial time point × 100]. In some cases, NH4Cl (20 mM) was added in the culture.
Cytokine assay
To observe cytokines in sera, mice were injected i.v. with 5 µg αGC. After 2 or 4 h, blood was collected. After clotting, IL-12p70, IL-4, and IFN-γ in the sera were assessed by a cytometric bead array (CBA, BD Bioscience). In some cases, Langerin-DTR mice or B6 mice were treated two times, 48 h apart, with 350 ng of DT or vehicle by i.p. injection to deplete Langerin + cells.
Immunostaining
Spleens were frozen in Tissue-Tek OCT-compound (SAKURA SEIKI Co., Ltd, Tokyo, Japan) at -20 ºC. Cryostat sections (10 µm in thickness) were dried, fixed in acetone for 10 min and then dried again. After Fc blocking with anti-CD16/32 mAb, sections were stained for 1 h with antibodies in staining buffer (1% FCS, 0.02% NaN3, 5 mM EDTA in PBS). Images were obtained with a fluorescence microscope BX51 (OLYMPUS, Tokyo, Japan). In some cases, mice were pulsed i.v. with Cy5-αGC, and spleen sections were prepared after 15 min. To observe the distribution of Langerin + DCs in the spleen, BALB/c mice were used, because of the low expression of Langerin in B6 mice.
Statistical analysis
Data are expressed as the mean ± SD of triplicate cultures or three mice in each group.
Statistical significances were determined by the Student's-t test. Differences were considered significant for p values < 0.05. All experiments were performed at least two times and representative results are shown.
Results and Discussion
CD8 + DCs effectively uptake more Cy-5-αGC than CD8 − DCs in vivo.
We Fig. 1E ) as reported previously [6] .
Then, we compared αGC uptake using its fluorescent derivative between CD8 + and CD8 -DCs in vivo. For precise comparisons, we used Jα18 KO mice that lacked iNKT cells [14] , as iNKT cells possibly killed mature cDCs that presented αGC. The mice were injected with Cy5-αGC, and fluorescence of cDC subsets was checked at various time points (Fig. 1 We then observed the uptake of Cy5-αGC in CD8 + and CD8 − DCs in vitro. Purified CD8 + and CD8 − DCs were co-cultured in vitro with Cy5-αGC to observe its incorporation.
Consistent with the in vivo results at all concentrations of Cy5-αGC ( Fig. 2A ) and incubation time points (Fig. 2B) (Fig. 2C) . However,
CD8
-DCs increased Cy5 fluorescence, but it was still lower than that of CD8 + DCs. We determined that Cy5 fluorescence was not affected from pH 7 to 4.5 (data not shown). These results suggest that CD8 + DCs take up more Cy5-αGC than CD8 − DCs, and that Cy5-αGC is degraded by the low pH of endosomes in CD8 − DCs. To further clarify this, cDCs were pulsed with Cy5-αGC for 30 min, and a change of fluorescence intensity was observed (Fig.   2D ). The results indicated that CD8 -DCs lost Cy5 fluorescence faster than CD8 + DCs. We then confirmed the presentation of the αGC/CD1d complex on the DCs using flow cytometry.
The results indicated that CD8 + DCs presented larger amounts of αGC/CD1d complex than CD8 − DCs at the concentrations we tested (Figs. 2E, F) . Langerin is one of the specific markers of splenic CD8 + DCs (Fig. 3A) .
Immunostaining with anti-Langerin mAb revealed that CD8 + DCs were primarily localized at the MZ, outer layer of SER4 + marginal metallophil, and bridging area (Fig. 3B) . After i.v.
injection, Cy5-αGC was observed in CD11c positive cells of MZ (Fig. 3C ) and CD31 + endothelial cells of blood vessels (Fig. 3D) . A weak Cy5 signal was also detected in the B cell area (Fig. 3C) . Including the results above ( Supplementary Fig. 1 and Fig. 1 ), these findings suggest that Langerin + CD8 + DCs are strategically located in MZ, especially adapted for sensing blood-borne antigens, and preferentially capture αGC in the spleen.
To define the relevance of capturing and presentation of αGC by the Langerin + CD8 + DCs, Langerin-DTR mice were treated with DT and injected i.v. with αGC. As shown in Fig. 3E , DT treatment effectively decreased CD8 + DCs in Langerin-DTR mice. In the control (PBS) treatment, Langerin-DTR mice produced comparative level of IL-12, but lower levels of IFN-γ and IL-4, compared to WT mice after αGC administration (Fig. 3F) . The reason for such low levels of IFN-γ and IL-4 is not clear. Nevertheless, in Langerin-DTR mice, DT treatment significantly decreased amounts of IFN-γ and IL-12, not IL-4, as previously reported by Farrand et al. [8] . Therefore, it is suggested that Langerin + CD8 + DCs in MZ capture αGC and lead to in vivo IFN-γ production by iNKT cells.
CD8 + DCs express larger amounts of membrane-bound CXCL16 than CD8
CXCL16 is a ligand of CXCR6 expressed in iNKT cells [17] . Although no difference of iNKT cell numbers was observed between WT and CXCR6-lacking mouse spleens, after treatment with αGC, IFN-γ-producing iNKT cells decreased significantly in the deficient mice [18] . It has also been suggested that membrane-bound CXCL16 on DCs mediates interactions with CXCR6 expressed on iNKT cells, leading to their adhesion/anchoring and full activation of iNKT cells [11, 19] . However, the expression of membrane-bound CXCL16 on cDC subsets is unknown. Before stimulation with αGC, CD8 + DCs expressed higher amounts of membrane-bound CXCL16 than CD8 -DCs (Fig. 4) . Four hours after αGC 
Conclusion
In cDC subsets, CD8 + DCs uptake αGC effectively compared with CD8 − DCs in vivo and in vitro. In addition, αGC is more stable in CD8 + DCs than in CD8 − DCs. It is possible that these two properties of CD8 + DCs result in their efficient accumulation and presentation of αGC. Furthermore, CD8 + DCs strategically localize in the MZ, which is specialized in capturing blood-borne antigens, and preferentially uptake αGC injected i.v. Furthermore, 
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1) We saw the fate of fluorescent α-galactosylceramide (Cy5-αGC) in vivo and in vitro.
2) CD8
+ dendritic cells (DCs) captured more αGC than CD8 − DCs in vivo and in vitro.
3) Cy5-αGC was more stable in CD8 + DCs than in CD8 − DCs. 
